Researchers wrote in the
journal Nature Medicine that studies "assessing the long-term safety of erythritol are warranted" given their findings.
In a narrow vote,
Food & Drug Administration advisers recommended Tuesday that the agency approved the country's first RSV vaccine for older people, a shot from Pfizer for people ages 60 and up.
News 12's Elizabeth Hashagen was joined by Dr. Sharon Nachman to talk about today's health headlines.